Since the pandemic began, Taiwan has developed several herbal formulas that traditional Chinese medicine doctors say are effective in treating COVID-19. The most prominent of these is Taiwan Chingguan Yihau (NRICM101), marketed under the name Respire Aid and developed by Taiwan’s National Research Institute of Chinese Medicine (NRICM). The treatment is made up of ten…

Bristol Myers Squibb (BMS) Taiwan General Manager Elbert Man’s people-centric outlook on life and work is a perfect match for the pharmaceutical industry. Man emphasizes transparency, respect for boundaries, and healthy debate as essential to fostering high-performing teams, a philosophy that has helped him advance through several country manager roles at international pharma companies.   Outside…

The use of artificial intelligence (AI) technologies in critical care has potentially lifesaving outcomes for long-term disease prevention and critical decisions during surgery. AI technologies can help medical professionals find biomarkers of disease, identify target molecules, discover drug candidates, speed up clinical trials, and even monitor and predict epidemic outbreaks. There is also a distinct…

By Courtney Donovan Smith Taishang Factories Disrupted by COVID-19 Taiwanese manufacturers in China, particularly those based in Shanghai and neighboring Kunshan, have suffered plant closures and supply chain issues due to China’s “dynamic zero-COVID” policies and the extended lockdown of the Shanghai region, widespread disruptions to trucking within China, and delays at the port of…

By Courtney Donovan Smith April Marks End to Zero-COVID Policy Locally transmitted cases in Taiwan have been rising exponentially since early April, as the Omicron variant began spreading across the island. Recognizing the variant’s infectiousness, the economic costs of the zero-COVID approach, and that almost all reported cases have been mild or asymptomatic, the government…

By Courtney Donovan Smith U.S. and Taiwan Discuss Bilateral Relations Though Taiwan was disappointed by the delay of an expected visit by U.S. House of Representatives Speaker Nancy Pelosi after she tested positive for COVID-19, other visits and meetings between Taiwan and the U.S. underscored the importance of the bilateral relationship as concerns grew that…

By Courtney Donovan Smith Experts Split On Economic Forecast Uncertainty about inflation and supply chain resilience have led various organizations to reach different projections about the economy’s direction this year. The Chung-Hua Institution for Economic Research (CIER) in April raised its forecast of Taiwan’s 2022 GDP growth by 0.29 percentage points to 3.96%. CIER attributed…